Viewing Study NCT06818266


Ignite Creation Date: 2025-12-24 @ 4:20 PM
Ignite Modification Date: 2025-12-24 @ 4:20 PM
Study NCT ID: NCT06818266
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-03-11
First Post: 2025-01-09
Is Possible Gene Therapy: False
Has Adverse Events: False

Brief Title: Efficacy and Safety of Tocilizumab for Acute Chest Syndrome Treatment in Patients With Sickle Cell Disease
Sponsor: Assistance Publique - Hôpitaux de Paris
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2025-04
Start Date Type: ESTIMATED
Primary Completion Date: 2027-04
Primary Completion Date Type: ESTIMATED
Completion Date: 2027-07
Completion Date Type: ESTIMATED
First Submit Date: 2025-01-09
First Submit QC Date: None
Study First Post Date: 2025-02-10
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-03-10
Last Update Post Date: 2025-03-11
Last Update Post Date Type: ACTUAL